Citation: Gp. Harrison et al., PAUSING OF REVERSE-TRANSCRIPTASE ON RETROVIRAL RNA TEMPLATES IS INFLUENCED BY SECONDARY STRUCTURES BOTH 5' AND 3' OF THE CATALYTIC SITE, Nucleic acids research, 26(14), 1998, pp. 3433-3442
Citation: Jf. Kaye et Aml. Lever, NONRECIPROCAL PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 RNA - A POSSIBLE ROLE FOR THE P2 DOMAIN OF GAG IN RNA ENCAPSIDATION, Journal of virology, 72(7), 1998, pp. 5877-5885
Citation: Gp. Harrison et al., FUNCTIONAL-ANALYSIS OF THE CORE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING SIGNAL IN A PERMISSIVE CELL-LINE, Journal of virology, 72(7), 1998, pp. 5886-5896
Citation: D. Haselhorst et al., DEVELOPMENT OF CELL-LINES STABLY EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINS FOR STUDIES IN ENCAPSIDATION AND GENE-TRANSFER, Journal of General Virology, 79, 1998, pp. 231-237
Authors:
EVANS GD
MENDELSON GMS
LEVER AML
BAGLIN TP
Citation: Gd. Evans et al., DEVELOPMENT OF AUTOANTIBODIES AND FACTOR-VIII INHIBITOR IN AN HIV-INFECTED HEMOPHILIAC FOLLOWING TREATMENT WITH COMBINATION ANTIRETROVIRAL THERAPY, British Journal of Haematology, 102(5), 1998, pp. 1382-1383
Citation: Ag. Filler et Aml. Lever, EFFECTS OF CATION SUBSTITUTIONS ON REVERSE-TRANSCRIPTASE AND ON HUMAN-IMMUNODEFICIENCY-VIRUS PRODUCTION, AIDS research and human retroviruses, 13(4), 1997, pp. 291-299
Authors:
RICHARDSON JH
HOLLSBERG P
WINDHAGEN A
CHILD LA
HAFLER DA
LEVER AML
Citation: Jh. Richardson et al., VARIABLE IMMORTALIZING POTENTIAL AND FREQUENT VIRUS LATENCY IN BLOOD-DERIVED T-CELL CLONES INFECTED WITH HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I, Blood, 89(9), 1997, pp. 3303-3314
Citation: G. Miele et Aml. Lever, EXPRESSION OF MUTANT AND WILD-TYPE GAG PROTEINS FOR GENE-THERAPY IN HIV-1 INFECTION, Gene therapy, 3(4), 1996, pp. 357-361
Authors:
GREATOREX JS
LAISSE V
DOKHELAR MC
LEVER AML
Citation: Js. Greatorex et al., SEQUENCES INVOLVED IN THE DIMERIZATION OF HUMAN T-CELL LEUKEMIA-VIRUSTYPE-1 RNA, Nucleic acids research, 24(15), 1996, pp. 2919-2923
Citation: D. Wilks et Aml. Lever, REASONS FOR DELAY IN ADMINISTRATION OF ANTIBIOTICS TO PATIENTS WITH MENINGITIS AND MENINGOCOCCEMIA, The Journal of infection, 32(1), 1996, pp. 49-51
Citation: Jf. Kaye et Aml. Lever, TRANS-ACTING PROTEINS INVOLVED IN RNA ENCAPSIDATION AND VIRAL ASSEMBLY IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 70(2), 1996, pp. 880-886
Authors:
MIELE G
MOULAND A
HARRISON GP
COHEN E
LEVER AML
Citation: G. Miele et al., THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 5'-PACKAGING SIGNAL STRUCTUREAFFECTS TRANSLATION BUT DOES NOT FUNCTION AS AN INTERNAL RIBOSOME ENTRY SITE STRUCTURE, Journal of virology, 70(2), 1996, pp. 944-951
Authors:
GREATOREX JS
LAISSE V
DOKHELAR MC
LEVER AML
Citation: Js. Greatorex et al., SEQUENCES INVOLVED IN DIMER FORMATION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 RNA, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 18-18
Authors:
ROSE NJ
RICHARDSON J
DESSELBERGER U
LEVER AML
Citation: Nj. Rose et al., TAX GENE ANALYSIS IN HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED T-CELL CLONES DISPLAYING PHENOTYPIC VARIATION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 147-147
Citation: Fmj. Guesdon et al., MASON-PFIZER MONKEY VIRUS (MPMV) AS A VECTOR FOR HUMAN GENE-THERAPY, Journal of cellular biochemistry, 1995, pp. 407-407
Citation: Gp. Harrison et al., SECONDARY STRUCTURE MODEL OF THE MASON-PFIZER MONKEY VIRUS 5' LEADER SEQUENCE - IDENTIFICATION OF A STRUCTURAL MOTIF COMMON TO A VARIETY OFRETROVIRUSES, Journal of virology, 69(4), 1995, pp. 2175-2186
Citation: Jf. Kaye et al., CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING, Journal of virology, 69(10), 1995, pp. 6588-6592